Liver, Pancreas and Biliary TractHepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Introduction
Nonalcoholic fatty liver disease (NAFLD) is believed to be a feature of metabolic syndrome because it is closely associated with visceral obesity, dyslipidaemia, insulin resistance, and type 2 diabetes mellitus (DM) [1]. Due to the increased prevalence of obesity, about 30% of the adult population now has NAFLD in the United States [2]. In Korea, the prevalence of NAFLD has been reported to be 16.1–27.2% and continues to increase due to the adoption of a Westernized lifestyle [3], [4], [5]. This high prevalence of NAFLD is probably problematic because patients with NAFLD show higher all-cause mortality and increased risks for liver-related death and cardiovascular disease [6], [7]. However, the screening of asymptomatic individuals using imaging modalities, such as ultrasonography (US) and computed tomography (CT), does not appear to be cost-effective because such studies are expensive for mass screening. Therefore, a simple, noninvasive test is required to identify patients at high risk of NAFLD and to establish an appropriate NAFLD screening programme. In this study, we aimed to derive a simple index based on standard laboratory tests and anthropometric parameters that can be used to determine the presence of NAFLD. In addition, we sought to validate this index in asymptomatic subjects.
Section snippets
Subjects
We performed a cross-sectional case–control study. A total of 21,130 adults who visited Seoul National University Hospital Gangnam Healthcare Center, Seoul, Korea for a routine health check-up between 1 January 2006 and 31 December 2006 participated in this study. NAFLD was defined as the presence of fatty liver disease by US in the absence of a potential cause of chronic liver disease, namely, (i) seropositivity for hepatitis B virus surface antigen (HBsAg) or anti-hepatitis C virus antibody
Baseline characteristics
Of the 21,130 participants, 3591 participants with at least one potential cause of chronic liver disease were excluded: 975 with hepatitis B, 242 with hepatitis C, 1690 with excessive alcohol consumption (>20 g/day), 593 taking medications known to produce fatty liver (steroids, oestrogens, tamoxifen, valproate, diltiazem, amiodarone, methotrexate, and so on) and 91 participants with other causes (Wilson's disease, haemochromatosis, primary biliary cirrhosis, autoimmune hepatitis, and so on). Of
Discussion
In the present study, we devised a novel index to detect the presence of NAFLD using BMI and the results of routinely performed laboratory tests. Moreover, the performance of HSI for detecting NAFLD was confirmed in the validation cohort.
Many studies have attempted to devise noninvasive methods that can predict the presence of NAFLD. Conventional radiological imaging studies, such as US, CT, and magnetic resonance imaging, have been shown to be reasonably accurate [11], [12], [13], [14]. For
Conflict of interest statement
None declared.
References (24)
- et al.
Diagnosis and therapy of nonalcoholic steatohepatitis
Gastroenterology
(2008) - et al.
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
Gastroenterology
(2005) - et al.
The utility of radiological imaging in nonalcoholic fatty liver disease
Gastroenterology
(2002) - et al.
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis
J Clin Epidemiol
(2001) - et al.
Introduction of fast MR imaging in the assessment of hepatic steatosis
Magn Reson Imaging
(1997) - et al.
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
Hepatology (Baltimore, MD)
(2003) - et al.
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Clin Radiol
(1991) - et al.
Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases
Dig Liver Dis
(2002) Nonalcoholic fatty liver disease
N Engl J Med
(2002)- et al.
Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults
J Gastroenterol Hepatol
(2006)
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults
Arch Intern Med
The association of nonalcoholic fatty liver disease with metabolic syndrome
J Korean Acad Fam Med
Cited by (895)
Predictive cut-off values for the triglyceride-to-high-density lipoprotein cholesterol ratio to predict metabolic syndrome in the middle-aged Korean population
2024, Nutrition, Metabolism and Cardiovascular DiseasesLongitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
2024, Clinical Gastroenterology and HepatologyApplication of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005–2023)
2024, Computer Methods and Programs in Biomedicine